date:Sep 17, 2015
for Kalsec in 1995.
Ingredion Inc. submitted a health claim petition to FDA for high-amylose corn resistant starch and reduction of risk for type 2 diabetes. Clinical studies conducted by academic institutions and research organizations on high-amylose corn resistant starch type 2 (RS2) have generated considerable scientific data supporting the health benefits of this ingredient.
We believe there is consistent scientific evidence showing a clear link between consumption of resistant starch fr